Skip to main content
SpringerLink
Log in

Safety and Efficacy Data for High-Dose Caspofungin

  • Clinical Trial Report
  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pappas PG, Kauffman CA, Andes D, et al.: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503–535.

    Article  PubMed  CAS  Google Scholar 

  2. Ernst ME, Klepser ME, Wolfe EJ, Pfaller MA: Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp. Diagn Microbiol Infect Dis 1996, 26:125–131.

    Article  PubMed  CAS  Google Scholar 

  3. Andes DR, Diekema DJ, Pfaller MA, et al.: In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model. Antimicrob Agents Chemother 2008, 52:3497–3503.

    Article  PubMed  CAS  Google Scholar 

  4. Stevens DA, Espiritu M, Parmar R: Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 2004, 48:3407–3411.

    Article  PubMed  CAS  Google Scholar 

  5. Arathoon EG, Gotuzzo E, Noriega LM, et al.: Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother 2002, 46:451–457.

    Article  PubMed  CAS  Google Scholar 

  6. Villanueva A, Arathoon EG, Gotuzzo E, et al.: A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis. Clin Infect Dis 2001, 33:1529–1535.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

  1. College of Pharmacy, Ferris State University, 1000 Oliver Street, Kalamazoo, MI, 49008, USA

    Michael E. Klepser

Authors
  1. Michael E. Klepser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael E. Klepser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klepser, M.E. Safety and Efficacy Data for High-Dose Caspofungin. Curr Fungal Infect Rep 4, 59–61 (2010). https://doi.org/10.1007/s12281-010-0017-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-010-0017-7

Keywords

Search

Navigation